Skip to main content

Epidemiology, Frequency, Distribution, Mechanisms, and Histopathology

  • Chapter
Oral Complications of Cancer Chemotherapy

Part of the book series: Developments in Oncology ((DION,volume 12))

Abstract

The number of newly diagnosed patients with malignant disease continues to rise annually. Fortunately, the prognostic outlook for these individuals is no longer universally grim. Significant progress has been made in understanding cancer biology and natural defense mechanisms and in the development of new and aggressive treatment modalities. There is evidence of an overall increase in survival time and, in a growing number of cases, the opportunity for curative therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Sonis ST, Sonis AL, Lieberman A: Oral complications in patients receiving treatment for malignancies other than of the head and neck. J Am Dent Assoc 97:468–472, 1978.

    PubMed  CAS  Google Scholar 

  2. Sonis AT, Sonis ST: Oral complications of cancer chemotherapy in pediatric patients. J Pedodontics 3:122–128, 1979.

    CAS  Google Scholar 

  3. Dreizen S, Bodey GP, Brown LR: Opportunistic gram-negative bacillary infections in leukemia. Oral manifestations during myelosuppression. Postgrad Med 55:133–139, 1974.

    PubMed  CAS  Google Scholar 

  4. The EORTC International Antimicrobial Therapy Project Group: Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. J Infect Dis 137:14–29, 1978.

    Article  Google Scholar 

  5. Guggenheimer J, Verbin RS, Appel BN, Schmitz J: Clinicopathologic effects of cancer chemotherapeutic agents on human buccal mucosa. Oral Surg 44:58—63, 1977.

    Article  PubMed  Google Scholar 

  6. Lockhart PB, Sonis ST: Relationship of oral complications to peripheral blood leukocyte and platelet counts in patients receiving cancer chemotherapy. Oral Surg 48:21—28, 1979.

    Article  PubMed  Google Scholar 

  7. Bodey GP: Oral manifestations of the myeloproliferative diseases. Postgrad Med 49:115–121, 1971.

    PubMed  CAS  Google Scholar 

  8. Lynch MA, Ship II: Initial oral manifestations of leukemia. J Am Dent Assoc 75:932–940, 1967.

    PubMed  CAS  Google Scholar 

  9. Stafford RF, Lockhart PB, Sonis AL, Sonis ST: Hematologic parameters as predictors of oral involvement in the presentation of acute leukemia. J Oral Med 37:38–41, 1982.

    PubMed  CAS  Google Scholar 

  10. Sonis AL, Sonis ST: Gingival crevice lymphoblasts in children with acute lymphoblastic leukemia. J Periodon- tol 52:276–279, 1981.

    CAS  Google Scholar 

  11. Barakat NJ, Toto PD, Choukas NC: Aging and cell renewal of oral epithelium. J Periodontol, 40:599–602, 1969.

    PubMed  CAS  Google Scholar 

  12. Overholser D, Peterson D, Williams L, Schimpff S: Periodontal infection in patients with acute nonlym- phocytic leukemia: Prevalence of acute exacerbation. Arch Intern Med 142:551–554, 1982.

    Article  PubMed  CAS  Google Scholar 

  13. Dreizen S, Bodey GP, Rodriguez V: Oral complications of cancer chemotherapy. Postgrad Med 58:95–82, 1975.

    Google Scholar 

  14. Volger W, Huguley C, and Kerr W: Toxicity and antitumor effect of divided doses of methotrexate. Arch Intern Med. 115:285–293, 1965.

    Google Scholar 

  15. Archibald D: Personal Communication.

    Google Scholar 

  16. Thomas ED, et al.: Bone marrow transplantation. N Engl J Med 292:895–902, 1975.

    Article  PubMed  CAS  Google Scholar 

  17. Brown LR, Dreizen S, Bodey GP: Effect of immunosuppression on the human oral flora. In Comparative Immunology of the Oral Cavity, Mergenhagen, SE Scherp HW (eds), DHEW Publication (NIH) 73–438,1973, pp. 204–220.

    Google Scholar 

  18. Sale GE, Shulman HM, Schubert MM, Sullivan KM, Kopecky KJ, Hackman RC, Morton TH, Szorb R, Thomas ED: Oral and ophthalmic pathology of graft versus host disease in man: predictive value of the lip biopsy. Hum Pathol 12:1022–1030, 1981.

    Article  PubMed  CAS  Google Scholar 

  19. Shklar G: The effect of 4-amino-N10-methyl-pterogl-glutamine acid on oral mucosa of experimental animals. J Oral Ther Pharmacol 4:374–377, 1968.

    PubMed  CAS  Google Scholar 

  20. Lockhart PB, Sonis ST: Alterations in the oral mucosa caused by chemotherapeutic agents. J Dermatol Surg Oncol 7:1019–1025, 1981.

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Martinus Nijhoff Publishing, The Hague/Boston/London

About this chapter

Cite this chapter

Sonis, S.T. (1983). Epidemiology, Frequency, Distribution, Mechanisms, and Histopathology. In: Peterson, D.E., Sonis, S.T. (eds) Oral Complications of Cancer Chemotherapy. Developments in Oncology, vol 12. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3912-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-3912-0_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-3914-4

  • Online ISBN: 978-1-4613-3912-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics